Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangyang Hao

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
BMC Medical Genomics|October 22, 2020
Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohortsYoonha Choi, Jianghan Qu, Shuyang Wu, et al.
Frontiers in Endocrinology|October 2, 2019
Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA SamplesTrevor E Angell, Lori J Wirth, Maria E Cabanillas, et al.
European Urology Oncology|May 11, 2025
Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate CancerNicole Handa, Eric V Li, Jamie Michael, et al.
The Journal of Clinical Endocrinology and Metabolism|December 5, 2022
Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysisChristian E Nasr, Massimiliano Andrioli, Mayumi Endo, et al.
Nature Communications|November 19, 2025
Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironmentSebastian Krossa, Maria K Andersen, Elise M Sandholm, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2021
Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid NodulesMimi I Hu, Steven G Waguespack, Chrysoula Dosiou, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 10, 2026
Development of Novel mRNA Classifiers to Stratify Preoperative Thyroid Tumor RiskThomas F Barrett, Mohamed Jama, Mohammed Alshalalfa, et al.
BJU International|February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
The Journal of Urology|June 20, 2025
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance TrialPedro F S Freitas, Archan Khandekar, Joao G Porto, et al.
Thyroid : Official Journal of the American Thyroid Association|July 6, 2022
Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing ClassifierGregory W Randolph, Julie Ann Sosa, Yangyang Hao, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
BMC Medical Genomics|October 22, 2020
Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohortsYoonha Choi, Jianghan Qu, Shuyang Wu, et al.
Frontiers in Endocrinology|October 2, 2019
Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA SamplesTrevor E Angell, Lori J Wirth, Maria E Cabanillas, et al.
European Urology Oncology|May 11, 2025
Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate CancerNicole Handa, Eric V Li, Jamie Michael, et al.
The Journal of Clinical Endocrinology and Metabolism|December 5, 2022
Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysisChristian E Nasr, Massimiliano Andrioli, Mayumi Endo, et al.
Nature Communications|November 19, 2025
Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironmentSebastian Krossa, Maria K Andersen, Elise M Sandholm, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2021
Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid NodulesMimi I Hu, Steven G Waguespack, Chrysoula Dosiou, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 10, 2026
Development of Novel mRNA Classifiers to Stratify Preoperative Thyroid Tumor RiskThomas F Barrett, Mohamed Jama, Mohammed Alshalalfa, et al.
BJU International|February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
The Journal of Urology|June 20, 2025
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance TrialPedro F S Freitas, Archan Khandekar, Joao G Porto, et al.
Thyroid : Official Journal of the American Thyroid Association|July 6, 2022
Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing ClassifierGregory W Randolph, Julie Ann Sosa, Yangyang Hao, et al.
Pageof 6